Trial Profile
Efficacy and Safety of an Antiviral Polymeric Nasal Spray: A Randomized, Parallel Group, Double-blind, Placebo-controlled Study in Subjects With Early Symptoms of Common Cold.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2012
Price :
$35
*
At a glance
- Drugs RC 591 (Primary)
- Indications Common cold
- Focus Therapeutic Use
- 08 May 2012 Actual patient number 163 added as reported by ClinicalTrials.gov.
- 08 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Apr 2012 Planned End Date changed from 1 Apr 2012 to 1 May 2012 as reported by ClinicalTrials.gov.